样式: 排序: IF: - GO 导出 标记为已读
-
The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-29 Guido Granata, Eskild Petersen, Alessandro Capone, Daniele Donati, Benedetta Andriolo, Maya Gross, Stefania Cicalini, Nicola Petrosillo
Scant data are available on the link between armed conflicts and the development and spread of antimicrobial resistance. We performed a systematic review with the aim to summarize the available data on the prevalence and features of antibiotic resistance and the causes of antibiotic resistance development during armed conflicts in the 21st century. Data sources: PubMed and SCOPUS databases were searched
-
Monetary incentives for vaccination: effectiveness and unintended consequences Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-29 Pol Campos-Mercade, Florian H. Schneider
-
Time to positivity is a risk factor for death among patients with bloodstream infections: a population-based cohort Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-29 Kevin B. Laupland, Felicity Edwards, Zoe Dettrick, Patrick N.A. Harris
Studies examining time to positivity (TTP) of blood cultures as a risk factor for death have shown conflicting results. The study objective was to examine the effect of TTP on all-cause-30-day case-fatality among a population-based cohort of patients with bloodstream infections (BSI). A retrospective cohort study including all residents of Queensland, Australia with incident monomicrobial BSI managed
-
Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020) Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-29 Olivier Paccoud, Marie Desnos-Ollivier, Florence Persat, Magalie Demar, Karine Boukris-Sitbon, Anne-Pauline Bellanger, Julie Bonhomme, Christine Bonnal, Françoise Botterel, Marie-Elisabeth Bougnoux, Sophie Brun, Sophie Cassaing, Estelle Cateau, Taieb Chouaki, Muriel Cornet, Eric Dannaoui, Nicole Desbois-Nogard, Marie-Fleur Durieux, Loïc Favennec, Arnaud Fekkar, Frederic Gabriel, Jean-Pierre Gangneux
-
‘Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland’ – Author's reply Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-29 Soheila Aghlmandi, Julia Bielicki, Heiner C. Bucher
-
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-28 Geert V.T. Roozen, Manon L.M. Prins, Corine Prins, Jacqueline J. Janse, Heidi L.M. de Gruyter, Cilia R. Pothast, Wesley Huisman, Jan Pieter R. Koopman, Olivia A.C. Lamers, Marjan Kuijer, Sebenzile K. Myeni, Rob S. van Binnendijk, Gerco den Hartog, Mirjam H.M. Heemskerk, Simon P. Jochems, Mariet C.W. Feltkamp, Marjolein Kikkert, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens
The aim of this study was to assess the safety and immunogenicity of a dose-sparing fractional intradermal (ID) booster strategy with the mRNA-1273 COVID-19 vaccine. COVID-19 naive adults aged 18–30 years were recruited from a previous study on primary vaccination regimens that compared 20 μg ID vaccinations with 100 μg intramuscular (IM) vaccinations with mRNA-1273 as the primary vaccination series
-
Ampicillin susceptibility testing of Haemophilus influenzae in the routine clinical laboratory by the EUCAST methodology compared to broth microdilution and the presence of ftsI gene mutations Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-28 Patrick D.J. Sturm, Noud T.H. Hermans, Adri G.M. van der Zanden, Cas J.A. Peters, Tanja Schülin
To investigate the prevalence of ampicillin resistance in and the diagnostic accuracy of the EUCAST recommended disc diffusion method to detect the increasingly prevalent ampicillin resistance due to the presence of PBP3 alterations based on mutations in the gene. During a 6-month period all consecutive non-duplicate isolates were prospectively collected and stored. MICs of ampicillin were determined
-
Stuck in pandemic uncertainty: a review of the persistent effects of COVID-19 infection in immune-deficient people Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-27 Bevin Manuelpillai, Mackenzie Zendt, Emma Chang-Rabley, Emily E. Ricotta
People who are immune-deficient/disordered (IDP) are underrepresented in COVID-19 studies. Specifically, there is limited research on post–SARS-CoV-2 infection outcomes, including viral persistence and long-term sequelae in these populations. This review aimed to examine the published literature on the occurrence of persistent SARS-CoV-2 positivity, relapse, reinfections, variant coinfection, and post-acute
-
Follow-up blood cultures do not reduce mortality in hospitalized patients with Gram-negative bloodstream infection: a retrospective population-wide cohort study Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-27 Sean W.X. Ong, Jin Luo, Daniel J. Fridman, Samantha M. Lee, Jennie Johnstone, Kevin L. Schwartz, Christina Diong, Samir N. Patel, Derek MacFadden, Bradley Langford, Steven Y.C. Tong, Kevin A. Brown, Nick Daneman
-
Characteristics, management and outcome of Herpes Simplex and Varicella-Zoster virus encephalitis: a multicentre prospective cohort study Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-26 Léa Poussier, Alexandra Mailles, Pierre Tattevin, Jean-Paul Stahl, Pierre Fillâtre, the scientific committee and investigators group, The investigators’ group are, Sophie Abgrall, Laurent Argaud, Xavier Argemi, Nathalie Asseray, Guillaume Baille, Aurélie Baldolli, Julien Biberon, Charlotte Biron, Geneviève Blanchet-Fourcade, Mathieu Blot, Anne Bonnetain, Elisabeth Botelho-Nevers, Frédéric Bourdain
-
Corrigendum to “Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis” [Clin Microbiol Infect 30 (2024) 189–196] Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-24 G. Zhou, S. Luo, J. He, N. Chen, Y. Zhang, S. Cai, X. Guo, H. Chen, C. Song
-
Gut microbiome diversity and composition in individuals with and without extended-spectrum β-lactamase-producing Enterobacterales carriage: a matched case–control study in infectious diseases department Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-23 Anders Boyd, Mariam El Dani, Roula Ajrouche, Vanessa Demontant, Justine Cheval, Karine Lacombe, Guillaume Cosson, Christophe Rodriguez, Jean-Michel Pawlotsky, Paul-Louis Woerther, Laure Surgers
Little is known about the effect of gut microbial and extended-spectrum β-lactamase-producing (ESBL-E) carriage, particularly in the general population. The aim of this study was to identify microbiota signatures uniquely correlated with ESBL-E carriage. We conducted a case–control study among individuals seeking care at the Sexual Health Clinic or Department of Infectious and Tropical Diseases, Saint-Antoine
-
The impact of the fluconazole trailing effect on the persistence of Candida albicans bloodstream infection when treated with fluconazole Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-23 Shang-Yi Lin, Ho-Yin Huang, Lin-Li Chang, Ya-Ling Wang, Tun-Chieh Chen, Ko Chang, Hung-Pin Tu, Po-Liang Lu
The trailing effect of species is a phenomenon characterized by reduced but persistent growth at antifungal concentrations above the MIC. We assessed the impact of trailing growth on the persistence of candidemia in patients receiving fluconazole (FLC) therapy. We retrospectively investigated candidemia isolates at three hospitals in southern Taiwan between 2013 and 2020. Patients treated with FLC
-
A prospective multicentre evaluation of BioFire® Joint Infection Panel for the rapid microbiological documentation of acute arthritis Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-23 Tiphaine Gaillard, Céline Dupieux-Chabert, Anne-Laure Roux, Eve Tessier, Adeline Boutet-Dubois, Camille Courboulès, Stéphane Corvec, Pascale Bémer, Jean-Philippe Lavigne, Faten El Sayed, Hélène Marchandin, Clément Munier, Emmanuel Chanard, Vincent Gazzano, Caroline Loiez, Frédéric Laurent
To assess the performance of the rapid syndromic BioFire® Joint Infection Panel (BF-JIP) to detect bacterial and fungal pathogens, as well as antibiotic resistance genes, directly in synovial fluid specimens collected from patients with acute arthritis. The study was conducted in six French bacteriological laboratories. To assess the performances of BF-JIP, results were compared with those of synovial
-
Prevalence of long COVID in the general adult population according to different definitions and sociodemographic and infection characteristics. A nationwide random sampling survey in France in autumn 2022 Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-23 Joël Coste, Cyrille Delpierre, Jean-Baptiste Richard, Caroline Alleaume, Anne Gallay, Sarah Tebeka, Cédric Lemogne, Olivier Robineau, Olivier Steichen, Tatjana T. Makovski
Long COVID has been recognized since early 2020, but its definition is not unanimous, which complicates epidemiological assessments. This study estimated the prevalence of long COVID based on several definitions and severity thresholds in the adult population of mainland France and examined variations according to sociodemographic and infection characteristics. A cross-sectional survey using random
-
Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-23 Marta Pozuelo Torres, Jakko van Ingen
Antibiotic treatment of disease is toxic and poorly effective and lacks a firm evidence base. Dual β-lactam and β-lactam/β-lactamase inhibitor combinations may be interesting leads to improve treatment outcomes. To summarize the current preclinical studies on dual β-lactam and β-lactam/β-lactamase inhibitor combinations against . We performed a literature search using the National Center for Biotechnology
-
Epidemiology of Escherichia coli bloodstream infection antimicrobial resistance trends across South West England during the first 2 years of the coronavirus disease 2019 pandemic response Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-23 Jack Stanley, Brian Sullivan, Andrew W. Dowsey, Koren Jones, Charles R. Beck
Between 2016 and 2019, the proportion of bloodstream infection (BSI) with resistance to at least one antibiotic increased nationally. Public health interventions implemented in response to the COVID-19 pandemic changed population contact patterns and healthcare systems, with consequent effects on epidemiological trends of numerous pathogens. We investigated the impact of COVID-19 restrictions on epidemiological
-
Cerebellar phaeohyphomycosis: a dark enigma Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-22 Neha Bhardwaj, Ashish Aggarwal, Harsimran Kaur, Shivaprakash M. Rudramurthy, Kirti Gupta
-
Phage resistance in Klebsiella pneumoniae and bidirectional effects impacting antibiotic susceptibility Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-22 Sue C. Nang, Jing Lu, Heidi H. Yu, Hasini Wickremasinghe, Mohammad A.K. Azad, Meiling Han, Jinxin Zhao, Gauri Rao, Phillip J. Bergen, Tony Velkov, Norelle Sherry, David T. McCarthy, Saima Aslam, Robert T. Schooley, Benjamin P. Howden, Jeremy J. Barr, Yan Zhu, Jian Li
-
Women's acceptance of two strategies for preventing respiratory syncytial virus infant bronchiolitis: maternal immunization or monoclonal antibodies for newborns Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-15 Axelle Roblin, Marie Lachâtre, Caroline Charlier, Odile Launay, Vassilis Tsatsaris, Olivia Anselem
-
Evaluation of two commercial broth microdilution systems for dalbavancin susceptibility testing of methicillin-resistant Staphylococcus aureus and other resistant Gram-positive cocci Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-15 Ilaria Baccani, Alberto Antonelli, Sara Cuffari, Caterina Ferretti, Tommaso Giani, Gian Maria Rossolini
This study aims to evaluate two commercial broth microdilution (BMD) systems, E1-185-100 (Merlin) and FDANDPF (ThermoFisher), for dalbavancin susceptibility testing in comparison with reference BMD assay. Study collection was composed of 200 non-replicate multidrug-resistant Gram-positive cocci of clinical origin, including 180 methicillin-resistant , 10 vancomycin-resistant enterococci, seven linezolid-resistant
-
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin regimen for rifampicin-resistant tuberculosis in Europe Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-13 Gunar Günther, Lorenzo Guglielmetti, Yousra Kherabi, Raquel Duarte, Christoph Lange, Tuberculosis Network European Trials group, Tonia Adamides, Onno Akkerman, Aase Bengaard Andersen, Ágnes Bakos, Agnar Bjarnason, Judith Bruchfeld, Dumitru Chesov, Luigi Ruffo Codecasa, Daniela Cirillo, Manfred Danilovits, Edita Davidavičienė, Raquel Duarte, Maria Luiza De Souza Galvão, Sandrine Garnier, Majlinda Gjocaj
Multidrug-resistant/rifampicin-resistant tuberculosis is a major obstacle to successful tuberculosis control. The recommendation by the WHO to use bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) for 6 months, based on results of three trials with high efficacy and low toxicity, has revolutionized treatment options. In this study, representatives of the Tuberculosis Network European Trials
-
Re: ‘Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland’ by Aghlmandi et al. Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-11 Catherine Plüss-Suard, Yolanda Mueller, Andreas Plate, Oliver Senn, Andreas Kronenberg
-
Diagnostic value of maternal, cord blood and neonatal biomarkers for early-onset sepsis: a systematic review and meta-analysis Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-11 Lisanne M. van Leeuwen, Elandri Fourie, Gerrie van den Brink, Vincent Bekker, Marlies A. van Houten
An accurate diagnosis of early-onset sepsis (EOS) is challenging because of subtle symptoms and the lack of a good diagnostic tool, resulting in considerable antibiotic overtreatment. A biomarker, discriminating between infected and non-infected newborns at an early stage of the disease, could improve EOS prediction. Numerous biomarkers have been tested, but have never been compared directly. We aimed
-
Bacterial load in cerebrospinal fluid predicts unfavourable outcome in pneumococcal meningitis: a prospective nationwide cohort study Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-11 Nora Chekrouni, Thijs M. van Soest, Ana C. da Cruz Campos, Matthijs C. Brouwer, Diederik van de Beek
The objective of this study was to determine the role of cerebrospinal fluid (CSF) bacterial load in adults with pneumococcal meningitis. We quantified bacterial load in CSF samples from the diagnostic lumbar puncture of adults with community-acquired pneumococcal meningitis. We also measured CSF concentrations of complement component 5a (C5a), and determined associations between bacterial load, clinical
-
Molecular detection of SARS-CoV-2 and other respiratory viruses in saliva and classroom air: a two winters tale Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-10 Nicolas Banholzer, Pascal Bittel, Philipp Jent, Lavinia Furrer, Kathrin Zürcher, Matthias Egger, Tina Hascher, Lukas Fenner
To compare the prevalence of SARS-CoV-2 and other respiratory viruses in saliva and bioaerosols between two winters and to model the probability of virus detection in classroom air for different viruses. We analysed saliva, air, and air cleaner filter samples from studies conducted in two Swiss secondary schools (students aged 14–17 years) over 7 weeks during the winters of 2021/22 and 2022/23. Two
-
Alarming increase in fluoroquinolone resistance among non-typhoidal salmonella isolates Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-09 Yeşim Beşli, Şiran Keske, Bilge E. Dikenelli, K. Erhan Palaoğlu, Önder Ergönül
-
Re: Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-09 Christian Garzoni, Enos Bernasconi, Cinzia Zehnder, Simona Frigerio Malossa, Giorgio Merlani, Marco Bongiovanni
-
New treatment options for critically important WHO fungal priority pathogens Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-09 Lisa Kriegl, Matthias Egger, Johannes Boyer, Martin Hoenigl, Robert Krause
Yet often overlooked in public health discourse, fungal infections pose a crucial global disease burden associated with annual mortality rates approximately equal to tuberculosis and HIV. In response, the WHO published its first global priority list of fungal pathogens in 2022 assigning , , , and to the critical group. This review provides succinct insights into novel antifungals in development, aiming
-
Pandemic preparedness beyond COVID-19: what we know, what we do, and what we do not Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-08 Juan M. Pericàs
-
Development and field validation of a reverse transcription loop-mediated isothermal amplification assay (RT-LAMP) for the rapid detection of chikungunya virus in patient and mosquito samples Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-08 Severino Jefferson Ribeiro da Silva, Jurandy Júnior Ferraz de Magalhães, Quinn Matthews, Ana Luisa Lot Divarzak, Renata Pessôa Germano Mendes, Bárbara Nazly Rodrigues Santos, Diego Guerra de Albuquerque Cabral, Jacilane Bezerra da Silva, Alain Kohl, Keith Pardee, Lindomar Pena
-
Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematological malignancies Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-08 Sarah Y. Park, Monica I. Ardura, Sean X. Zhang
Pulmonary invasive fungal infections (pIFI) disproportionately affect patients with haematological malignancies (HM). Establishing a rapid and accurate diagnosis of pIFI is challenging. Multiple guidelines recommend diagnostic testing of invasive fungal infections but lack consensus and may contribute to inconsistent diagnostic approaches. To identify key diagnostic challenges and review metagenomic
-
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-08 Anthony Febres-Aldana, Fareed Khawaja, Oscar Morado-Aramburo, Terri Lynn Shigle, Gabriela Rondon, Joseph Sassine, Amy Spallone, Krithika Srinivasan, Jeremy Ramdial, Amin Alousi, Richard Champlin, George Chen, May Daher, Katayoun Rezvani, Ella J. Ariza-Heredia, Elizabeth J. Shpall, Roy F. Chemaly
Allogeneic haematopoietic cell transplant (allo-HCT) recipients who are cytomegalovirus (CMV)-seronegative have better post-transplant outcomes than CMV-seropositive recipients. Letermovir (LTV) is approved for CMV primary prophylaxis in adults who are CMV-seropositive after allo-HCT, and its use is associated with improved long-term post-transplant outcomes. We analysed whether LTV has affected the
-
A family cluster of Streptococcus pyogenes associated with a fatal early-onset neonatal sepsis Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-02 Federica Novazzi, Lorenzo Colombini, Simona Perniciaro, Angelo Genoni, Massimo Agosti, Francesco Santoro, Nicasio Mancini
-
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study on the behalf of G2I and Intergroupe Francophone du Myélome Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-01 Aurélie Jourdes, Elise Cellerin, Cyrille Touzeau, Stéphanie Harel, Blandine Denis, Guillaume Escure, Emmanuel Faure, Simon Jamard, Francois Danion, Cécile Sonntag, Florence Ader, Lionel Karlin, Sarah Soueges, Clarisse Cazelles, Clémentine de La Porte des Vaux, Laurent Frenzel, Fanny Lanternier, Xavier Brousse, Titouan Cazaubiel, Pierre Berger, Aude Collignon, Mathieu Blot, Andrea Pieragostini, Morgane
Bispecific antibodies (BsAbs) are an effective treatment used in relapsed or refractory multiple myeloma. Despite a well-tolerated safety profile, infectious events appear to be frequent in clinical trials. Real-world data on epidemiology, characteristics, risk factors, and outcomes of infections in patients treated with BsAb are still needed. A retrospective, multicentre study in BsAb-treated patients
-
Is the T2 magnetic resonance imaging Candida panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice? Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-03-01 Iris Camp, Astrid Füszl, Brigitte Selitsch, Ivonne Kröckel, Katharina Kovac, Martin Wahrmann, Barbara Steinlechner, Johannes Weber, Peter Schellongowski, Christian Zauner, Guerkan Sengölge, Tamara Seitz, Alexander Zoufaly, Barbara Ströbele, Stefan Fuchs, Cornelia Lass-Flörl, Heinz Burgmann, Michael Kundi, Birgit Willinger
The diagnosis of invasive infection remains challenging because of tests with slow turnaround times or mediocre performance. T2magnetic resonance imaging is a new diagnostic tool. We investigated the diagnostic accuracy of the T2Candida panel (T2) in comparison with blood culture (BC) and the SeptiFast (SF) for the detection of five different species among high-risk intensive care unit patients with
-
COVID-19 mortality among selective serotonin reuptake inhibitor users: author's reply Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-29 Marius Ahm Stauning, Dogukan Jesper Gür, Christian Torp-Pedersen, Jens Tingleff
-
World Health Organization World Hand Hygiene Day, 5 May 2024. SAVE LIVES: Clean Your Hands campaign: Promoting knowledge and capacity building on infection prevention and control, including hand hygiene, among health and care workers Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-29 Claire Kilpatrick, Ermira Tartari, Miranda Deeves, Didier Pittet, Benedetta Allegranzi
-
Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-29 Malgorzata Mikulska, Nadir Ullah, Laura Magnasco, Giulia Codda, Claudia Bartalucci, Franca Miletich, Chiara Sepulcri, Edward Willison, Antonio Vena, Daniele R. Giacobbe, Vincenzo di Pilato, Chiara Robba, Lorenzo Ball, Anna Marchese, Matteo Bassetti
The serum (1,3)-beta--glucan (BDG) assay gives quicker results and has higher sensitivity than blood cultures, therefore it is advised for early diagnosis of invasive candidemia and/or discontinuation of empirical therapy. Its sensitivity may depend on different factors. The aim of our study was to analyse the and BDG levels in clinical isolates of three species of responsible for candidemia. and strains
-
Cuterebra sp tracheopulmonary myiasis in a traveller returning from Costa Rica Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-28 Léo-Pol Rio, Guilhem Conquet, Brigitte Langlois, Emmanuelle Varlet-Marie, Laurence Lachaud, Grégoire Pasquier
-
Psoriasis with Stemphylium lycopersici infection Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-27 Ya Min Yang, Dong Ming Li
-
Evolutionary dynamics of the novel ST22-PT methicillin-resistant Staphylococcus aureus clone co-harbouring Panton–Valentine leucocidin and duplicated toxic shock syndrome toxin 1 genes Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-24 Tetsuo Yamaguchi, Kenji Furuno, Kohji Komori, Tomoko Abe, Takahiro Sato, Shinji Ogihara, Kotaro Aoki, Yoshikazu Ishii, Kazuhiro Tateda
-
All you want to know about Mycobacterium abscessus Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-23 Emmanuelle Cambau, Giovanni Delogu, Jakko van Ingen, Jean-Louis Herrmann, Kevin Winthrop
-
Etiological agent and clinical characteristics of haemorrhagic fever with renal syndrome in the southern Republic of Korea: a genomic surveillance study Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-23 Sara P. Prayitno, Augustine Natasha, Seonghyeon Lee, Choon-Mee Kim, You Mi Lee, Kyungmin Park, Jongwoo Kim, Seong-Gyu Kim, Jieun Park, Shivani Rajoriya, Gustavo Palacios, Yeonsu Oh, Jin-Won Song, Dong-Min Kim, Won-Keun Kim
High incidences of haemorrhagic fever with renal syndrome (HFRS) have been reported in the southern Republic of Korea (ROK). A distinct southern genotype of (HTNV) was identified in on Jeju Island. However, its association with HFRS cases in southern ROK remains elusive. We investigated the potential of the southern HTNV genotype as an etiological agent of HFRS. Samples from 22 patients with HFRS and
-
Identification of gaps in the performance of routine microscopy for the diagnosis of parasitic infections revealed by the Dutch laboratory quality assessment scheme Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-23 Marrit B. Boonstra, Rob Koelewijn, Eric A.T. Brienen, Kim Tassche-Borggreve, Laetitia M. Kortbeek, Theo G. Mank, Bert Mulder, Foekje Stelma, Lisette van Lieshout, Jaap J. van Hellemond
-
First evidence of a mother-to-child transmission of an HIV-1/MO intergroup recombinant form Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-21 Manon Vautrin, Fabienne Tombette, Vinca Icard, Marie Leoz, Mary-Anne Trabaud, Antoine Ouziel, Luc Panetta, Véronique Lemée, Jean-Christophe Plantier, Alice Moisan
-
Orthopox viruses: is the threat growing? Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-20 Erik Boehm, Kathrin Summermatter, Laurent Kaiser
Smallpox was a major cause of human mortality until its eradication, but the threat of orthopox viruses has not disappeared. Since the eradication of smallpox and the cessation of the related vaccination campaigns, the threat has been growing, as evidenced by the currently ongoing worldwide Mpox outbreak. In addition to threats of an evolving Mpox, we must also be aware of a myriad of other threats
-
Lack of detection of Klebsiella aerogenes sub-species in lung infection by the BioFire® FilmArray® pneumonia Panel plus Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-16 Nathan Nicolau-Guillaumet, Laurent Dortet, Aymeric Jacquemin, Bruno Mourvillier, Anaëlle Muggeo, Thomas Guillard
-
Exploring the significance of delayed delivery of antibiotics in the community Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-16 Adi Turjeman
-
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared with the reference standard—author's reply Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-14 Helmut J.F. Salzer, Christoph Lange
-
Re: ‘COVID-19 mortality among selective serotonin reuptake inhibitor users’ by Stauning et al. Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-10 Carla P. Rus, J.J. Sandra Kooij
-
WHO’s essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-09 Lorenzo Moja, Veronica Zanichelli, Dominik Mertz, Sumanth Gandra, Bernadette Cappello, Graham S. Cooke, Pem Chuki, Stephan Harbarth, Celine Pulcini, Marc Mendelson, Evelina Tacconelli, Loice Achieng Ombajo, Ronald Chitatanga, Mei Zeng, Monica Imi, Christelle Elias, Per Ashorn, Annamaria Marata, Sarah Paulin, Arno Muller, Awa Aidara-Kane, Teodora Elvira Wi, Wilson Milton Were, Elizabeth Tayler, Albert
The WHO Model List of Essential Medicines (EML) prioritizes medicines that have significant global public health value. The EML can also deliver important messages on appropriate medicine use. Since 2017, in response to the growing challenge of antimicrobial resistance, antibiotics on the EML were reviewed and categorized into three groups: Access, Watch and Reserve, leading to a new categorization
-
Major cardiovascular events after COVID-19 in people with HIV Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-09 Raquel Martín-Iguacel, Sergio Moreno-Fornés, Andreu Bruguera, Jordi Aceitón, Daniel Kwakye Nomah, Ana González-Cordón, Pere Domingo, Adrian Curran, Arkaitz Imaz, David Dalmau Juanola, Joaquim Peraire, Beatriz Borjabad, Laia Arbones Fernandez, Isik Somuncu Johansen, José M. Miró, Jordi Casabona, Josep M. Llibre, PISCIS study group
To assess the effect of COVID-19 on the postacute risk of cardiovascular events (CVEs) among people with HIV (PWH). Population-based matched cohort, including all PWH ≥16 years in the Catalan PISCIS HIV cohort. We estimated the incidence rate of the first CVE after COVID-19, analysed it a composite outcome (2020–2022). We adjusted for baseline differences using inverse probability weighting and used
-
Information bias for case definitions and mortality between and within studies over time undermines our understanding of COVID-19 transmission and disease severity Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-08 Daniel Pan, Hidekazu Nishimura, Julian W. Tang
-
Which trial do we need? Percutaneous mechanical aspiration versus medical management alone for treatment of right-sided valvular infective endocarditis Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-08 Molly Hillenbrand, Ahmad Mourad, Thomas L. Holland, Nicholas A. Turner
-
Effectiveness of financial incentives on influenza vaccination among older adults in China: A randomized clinical trial Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-08 Yang Shen, Jingyu Wang, Jian Wang, Stephen Nicholas, Elizabeth Maitland, Min Lv, Tao Yin, Dawei Zhu
To investigate the short-term and long-term effectiveness of different level of financial incentives on increasing the willingness to vaccinate and vaccine uptake. A randomized controlled trial was conducted to investigate the effectiveness of financial incentives of three groups with monetary incentives (CNY20, CNY40, and CNY60; 1 CNY=0.13EUR) vs a control group - CNY0- on influenza vaccine uptake
-
Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-07 Joshua Osowicki, Fergus Hamilton, Todd C. Lee, Michael Marks, Erin K. McCreary, Emily G. McDonald, Jonathan H. Ryder, Steven Y.C. Tong
-
Re: ‘The Effect of Antibiotic Therapy for Clostridioides difficile Infection on Mortality and Other Patient-Relevant Outcomes’ by Stabholz et al. Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-06 I-Wen Chen, Chia-Li Kao, Kuo-Chuan Hung
-
Safeguarding COVID-19 vaccines: establishing the safety of novel vaccine platforms Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-06 David Shasha
-
Vaccination and the risk of post-acute sequelae after COVID-19 in the Omicron-predominant period Clin. Microbiol. Infect. (IF 14.2) Pub Date : 2024-02-06 Kyungmin Huh, Young-Eun Kim, Gi Hwan Bae, Jong Youn Moon, Ji-Man Kang, Jacob Lee, Jang-Whan Bae, Kyong Ran Peck, Jaehun Jung
To assess the association of primary and third doses of vaccination with the risk of post-acute sequelae of COVID-19. This retrospective cohort study utilized a combined database of nationwide healthcare claims data, COVID-19 patient registry, and vaccination records from South Korea. Individuals diagnosed with COVID-19 in the Omicron variant-dominant period of January to March 2022 were tracked for